Growth Metrics

Innoviva (INVA) EBITDA Margin (2016 - 2025)

Innoviva (INVA) has disclosed EBITDA Margin for 16 consecutive years, with 115.73% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, EBITDA Margin rose 6742.0% year-over-year to 115.73%, compared with a TTM value of 51.95% through Sep 2025, down 3130.0%, and an annual FY2025 reading of 39.81%, down 671.0% over the prior year.
  • EBITDA Margin was 115.73% for Q3 2025 at Innoviva, up from 48.61% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 8265.41% in Q2 2021 and bottomed at 2306.72% in Q2 2023.
  • Average EBITDA Margin over 5 years is 284.41%, with a median of 48.31% recorded in 2024.
  • The sharpest move saw EBITDA Margin surged 816941bps in 2021, then plummeted -954226bps in 2022.
  • Year by year, EBITDA Margin stood at 611.53% in 2021, then crashed by -61bps to 982.68% in 2022, then skyrocketed by 56bps to 430.5% in 2023, then crashed by -98bps to 853.36% in 2024, then skyrocketed by 114bps to 115.73% in 2025.
  • Business Quant data shows EBITDA Margin for INVA at 115.73% in Q3 2025, 48.61% in Q2 2025, and 9.24% in Q1 2025.